|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Serum levels of TNF - alpha, IFN - gamma,IL -6 ,IL - 8, IL - 12,IL - 17, and IL - 18 in patients with active psoriasis and correlation with disease severity 显示文摘 | Arican O Aral M Sasmaz S | 2005 | Mediators Inflamm2005，24，5： | 1 |
| 2 | Serum levels of TNF- alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17 and IL-18 in patients with active psoriasis and correlation with disease severity显示文摘 | Arican O Aral M Sasmaz S | 2005 | Mediators Inflamm2005，，5： | 1 |
| 3 | Serum levels of TNF- alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity 显示文摘 | Arican O Aral M Sasmaz S | 2005 | Mediators Inflamm2005，2005，5： | 1 |
| 4 | Synthesis and characterization of phthalocyanines containing phenothiazine moieties显示文摘 | SASMAZ S ACJAR E AOAR A | 1999 | Dyes Pigments1999，42，： | 1 |
| 5 | Serum levels of TNF-α,IFN-γ,IL-6,IL-8,IL-12,IL-17,and IL-18 in patients with active psoriasis and correlation with disease severity显示文摘 | Arican O Aral M Sasmaz S | 2005 | Mediators of Inflammation2005，，5： | 1 |
| 6 | Serum levels of TNF- alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17 and IL-18 in patients with active psoriasis and correlation with disease severity 显示文摘 | Arican O Aral M Sasmaz S | 2005 | Mediators Inflamm2005，2005，5： | 1 |
| 7 | Comparison of azelaic acid and anthralin for the therapy of patchy alopecia areata: a pilot study显示文摘 | Sasmaz S Ariean O | 2005 | Am J Clin Dermatol2005，6，6： | 1 |
| 8 | Serum levels of TNF-α,IFN-γ,IL-6,IL-8,IL-12,IL-17,and IL-18 in patients with active psoriasis and correlation with disease severity显示文摘 | Arican O Aral M Sasmaz S | | 0，，： | 1 |
| 9 | Serum levels of TNF- alpha,IFN-gamma,IL-6,IL-8, IL-12,IL-17,and IL-18 in patients with active psoriasis and correlation with dis- ease severity 显示文摘 | Arican O Aral M Sasmaz S | 2005 | Mediators of Inflammation2005，2005，5： | 1 |
| 10 | Serum levels of TNF-e, IFN-α, IL-6, IL-8, IL-12, IL-17, and IL- 18 in patients with active psoriasis and correla- tion with disease severity 显示文摘 | Arican O Aral M Sasmaz S | 2005 | Mediators Inflam- mation2005，2005，5： | 1 |
| 11 | Acute results of per- cutaneous mitral balloon valvuloplasty显示文摘 | Korkmaz S Aksu T Sasmaz H | 2011 | Turk Kardiyol Dern Ars2011，39，2： | 1 |
| 12 | Giant vascular eccrine spiradenoma显示文摘 | SENOL M OZCAN A SASMAZ S | 1998 | Int J Dermatol1998，37，3： | 1 |
| 13 | Serum levels of TNF alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity显示文摘 | Arican O Aral M Sasmaz S | 2005 | Mediators Inflamm2005，2005，5： | 1 |
| 14 | Serum levels of TNF-alpha,IFN-gamma,IL-6,IL-8,IL-12,IL-17,and IL-18 in patients with active psoriasis and correlation with disease severity显示文摘 | Arican O Aral M Sasmaz S | | 0，，： | 1 |
| 15 | Mercury adsorption on PdAu, PdAg and PdCu alloys 显示文摘 | Aboud S Sasmaz E Wilcox J | 2008 | Main Group Chemistry2008，7，3： | 1 |
| 16 | Serum levels of TNF-alpha,IFN-gamma,IL-6,IL-8,IL-12,IL-17,and IL-18 in patients with activepsoriasis and correlation with disease severity显示文摘 | Arican O Aral M Sasmaz S | 2005 | Mediators In-flamm2005，，5： | 1 |
| 17 | Serum levels of TNF-α,IFN-γ,IL-6,IL-8,IL-12,IL-17,and IL-18 in patients with active psoriasis and correlation with disease severity显示文摘 | Arican O Aral M Sasmaz S | 2005 | Mediators Inflamm2005，5，： | 1 |
| 18 | Serum levels of TNF- alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity 显示文摘 | ARICAN O ARAL M SASMAZ S | 2005 | Mediators Inflamm2005，2005，5： | 1 |
| 19 | Serum levels of TNF-α , IFN-β, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity 显示文摘 | Arican O Aral M Sasmaz S | 2005 | Mediators of Inflammation2005，，5： | 1 |
| 20 | Serum levels of TNF-alpha,IFN-gamma,IL-6,IL-8,IL-12,IL-17,and IL-18in patients with active psoriasis and correlation with dis-ease severity显示文摘 | Arican O Aral M Sasmaz S | 2005 | Mediators Inflamm2005，2005，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员